05.08.26 -- Implementing A New CEO Strategy With NervGen Leaders

As global pricing reforms evolve and policies gain traction, stakeholders must critically reassess the role of International Reference Pricing in balancing affordability, access, and incentives for innovation.

See how early identification of CQAs can streamline mRNA drug product development, reduce risk, and align with evolving regulatory expectations.

Hear how one family, driven by urgency, partnered with AAV experts to develop a treatment for their daughter’s ultra-rare neurodegenerative disorder, NEDAMSS, in just 14 months.

Modern oncology needs adaptive, data-driven dose finding. Learn why traditional methods fall short and how model-assisted and model-based designs improve decisions.

Explore how AI‑powered search, intelligent data capture, and ontology‑driven structure streamline scientific discovery and documentation, as well as how structured data unlocks smarter analysis.

In an increasingly competitive and regulated landscape, the right ERP system is no longer optional — it’s essential to reclaim control and drive growth in pharmaceutical manufacturing.

Discover the benefits of Australia as a premier destination for multinational sponsors looking to expedite drug development, refine trial design, and establish long-term research partnerships.

Learn how lyophilization revolutionizes biologic drug manufacturing and ensures potent, stable treatments for complex diseases.